Mast Cell Activation and KSHV Infection in Kaposi Sarcoma

Kaposi sarcoma (KS) is a vascular tumor initiated by infection of endothelial cells (ECs) with KS-associated herpesvirus (KSHV). KS is dependent on sustained proinflammatory signals provided by intralesional leukocytes and continued infection of new ECs. However, the sources of these cytokines and i...

Full description

Saved in:
Bibliographic Details
Published inClinical cancer research Vol. 24; no. 20; pp. 5085 - 5097
Main Authors Ayers, Leona W, Barbachano-Guerrero, Arturo, McAllister, Shane C, Ritchie, Julie A, Asiago-Reddy, Elizabeth, Bartlett, Linda C, Cesarman, Ethel, Wang, Dongliang, Rochford, Rosemary, Martin, Jeffrey N, King, Christine A
Format Journal Article
LanguageEnglish
Published United States 15.10.2018
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Kaposi sarcoma (KS) is a vascular tumor initiated by infection of endothelial cells (ECs) with KS-associated herpesvirus (KSHV). KS is dependent on sustained proinflammatory signals provided by intralesional leukocytes and continued infection of new ECs. However, the sources of these cytokines and infectious virus within lesions are not fully understood. Here, mast cells (MCs) are identified as proinflammatory cells within KS lesions that are permissive for, and activated by, infection with KSHV. Three validated MC lines were used to assess permissivity of MCs to infection with KSHV and to evaluate MCs activation following infection. Biopsies from 31 AIDS-KS cases and 11 AIDS controls were evaluated by IHC for the presence of MCs in KS lesions and assessment of MC activation state and infection with KSHV. Plasma samples from 26 AIDS-KS, 13 classic KS, and 13 healthy adults were evaluated for levels of MC granule contents tryptase and histamine. In culture, MCs supported latent and lytic KSHV infection, and infection-induced MC degranulation. Within KS lesions, MCs were closely associated with spindle cells. Furthermore, MC activation was extensive within patients with KS, reflected by elevated circulating levels of tryptase and a histamine metabolite. One patient with clinical signs of extensive MC activation was treated with antagonists of MC proinflammatory mediators, which resulted in a rapid and durable regression of AIDS-KS lesions. Using complimentary and studies we identify MCs as a potential long-lived reservoir for KSHV and a source of proinflammatory mediators within the KS lesional microenvironment. In addition, we identify MC antagonists as a promising novel therapeutic approach for KS. .
AbstractList Kaposi sarcoma (KS) is a vascular tumor initiated by infection of endothelial cells (ECs) with KS-associated herpesvirus (KSHV). KS is dependent on sustained proinflammatory signals provided by intralesional leukocytes and continued infection of new ECs. However, the sources of these cytokines and infectious virus within lesions are not fully understood. Here, mast cells (MCs) are identified as proinflammatory cells within KS lesions that are permissive for, and activated by, infection with KSHV. Three validated MC lines were used to assess permissivity of MCs to infection with KSHV and to evaluate MCs activation following infection. Biopsies from 31 AIDS-KS cases and 11 AIDS controls were evaluated by IHC for the presence of MCs in KS lesions and assessment of MC activation state and infection with KSHV. Plasma samples from 26 AIDS-KS, 13 classic KS, and 13 healthy adults were evaluated for levels of MC granule contents tryptase and histamine. In culture, MCs supported latent and lytic KSHV infection, and infection-induced MC degranulation. Within KS lesions, MCs were closely associated with spindle cells. Furthermore, MC activation was extensive within patients with KS, reflected by elevated circulating levels of tryptase and a histamine metabolite. One patient with clinical signs of extensive MC activation was treated with antagonists of MC proinflammatory mediators, which resulted in a rapid and durable regression of AIDS-KS lesions. Using complimentary and studies we identify MCs as a potential long-lived reservoir for KSHV and a source of proinflammatory mediators within the KS lesional microenvironment. In addition, we identify MC antagonists as a promising novel therapeutic approach for KS. .
Abstract Purpose: Kaposi sarcoma (KS) is a vascular tumor initiated by infection of endothelial cells (ECs) with KS–associated herpesvirus (KSHV). KS is dependent on sustained proinflammatory signals provided by intralesional leukocytes and continued infection of new ECs. However, the sources of these cytokines and infectious virus within lesions are not fully understood. Here, mast cells (MCs) are identified as proinflammatory cells within KS lesions that are permissive for, and activated by, infection with KSHV. Experimental Design: Three validated MC lines were used to assess permissivity of MCs to infection with KSHV and to evaluate MCs activation following infection. Biopsies from 31 AIDS-KS cases and 11 AIDS controls were evaluated by IHC for the presence of MCs in KS lesions and assessment of MC activation state and infection with KSHV. Plasma samples from 26 AIDS-KS, 13 classic KS, and 13 healthy adults were evaluated for levels of MC granule contents tryptase and histamine. Results: In culture, MCs supported latent and lytic KSHV infection, and infection-induced MC degranulation. Within KS lesions, MCs were closely associated with spindle cells. Furthermore, MC activation was extensive within patients with KS, reflected by elevated circulating levels of tryptase and a histamine metabolite. One patient with clinical signs of extensive MC activation was treated with antagonists of MC proinflammatory mediators, which resulted in a rapid and durable regression of AIDS-KS lesions. Conclusions: Using complimentary in vitro and in vivo studies we identify MCs as a potential long-lived reservoir for KSHV and a source of proinflammatory mediators within the KS lesional microenvironment. In addition, we identify MC antagonists as a promising novel therapeutic approach for KS. Clin Cancer Res; 24(20); 5085–97. ©2018 AACR.
Purpose: Kaposi sarcoma (KS) is a vascular tumor initiated by infection of endothelial cells (ECs) with KS-associated herpesvirus (KSHV). KS is dependent on sustained proinflammatory signals provided by intralesional leukocytes and continued infection of new ECs. However, the sources of these cytokines and infectious virus within lesions are not fully understood. Here, mast cells (MCs) are identified as proinflammatory cells within KS lesions that are permissive for, and activated by, infection with KSHV.Experimental Design: Three validated MC lines were used to assess permissivity of MCs to infection with KSHV and to evaluate MCs activation following infection. Biopsies from 31 AIDS-KS cases and 11 AIDS controls were evaluated by IHC for the presence of MCs in KS lesions and assessment of MC activation state and infection with KSHV. Plasma samples from 26 AIDS-KS, 13 classic KS, and 13 healthy adults were evaluated for levels of MC granule contents tryptase and histamine.Results: In culture, MCs supported latent and lytic KSHV infection, and infection-induced MC degranulation. Within KS lesions, MCs were closely associated with spindle cells. Furthermore, MC activation was extensive within patients with KS, reflected by elevated circulating levels of tryptase and a histamine metabolite. One patient with clinical signs of extensive MC activation was treated with antagonists of MC proinflammatory mediators, which resulted in a rapid and durable regression of AIDS-KS lesions.Conclusions: Using complimentary in vitro and in vivo studies we identify MCs as a potential long-lived reservoir for KSHV and a source of proinflammatory mediators within the KS lesional microenvironment. In addition, we identify MC antagonists as a promising novel therapeutic approach for KS. Clin Cancer Res; 24(20); 5085-97. ©2018 AACR.
Author Cesarman, Ethel
McAllister, Shane C
Wang, Dongliang
Barbachano-Guerrero, Arturo
Bartlett, Linda C
Rochford, Rosemary
Martin, Jeffrey N
Asiago-Reddy, Elizabeth
Ritchie, Julie A
Ayers, Leona W
King, Christine A
AuthorAffiliation 1 Department of Pathology, The Ohio State University, Columbus, Ohio
4 Department of Medicine, SUNY Upstate Medical University, Syracuse, NY
3 Department of Pediatrics, University of Minnesota Medical School, Minneapolis, MN
6 Department of Public Health and Preventative Medicine, SUNY Upstate Medical University, Syracuse, NY
7 Department of Epidemiology and Biostatistics, University of California, San Francisco, CA
2 Department of Microbiology and Immunology, SUNY Upstate Medical University, Syracuse, NY
5 Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY
AuthorAffiliation_xml – name: 1 Department of Pathology, The Ohio State University, Columbus, Ohio
– name: 5 Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY
– name: 7 Department of Epidemiology and Biostatistics, University of California, San Francisco, CA
– name: 4 Department of Medicine, SUNY Upstate Medical University, Syracuse, NY
– name: 2 Department of Microbiology and Immunology, SUNY Upstate Medical University, Syracuse, NY
– name: 3 Department of Pediatrics, University of Minnesota Medical School, Minneapolis, MN
– name: 6 Department of Public Health and Preventative Medicine, SUNY Upstate Medical University, Syracuse, NY
Author_xml – sequence: 1
  givenname: Leona W
  surname: Ayers
  fullname: Ayers, Leona W
  organization: Department of Pathology, The Ohio State University, Columbus, Ohio
– sequence: 2
  givenname: Arturo
  surname: Barbachano-Guerrero
  fullname: Barbachano-Guerrero, Arturo
  organization: Department of Microbiology and Immunology, SUNY Upstate Medical University, Syracuse, New York
– sequence: 3
  givenname: Shane C
  surname: McAllister
  fullname: McAllister, Shane C
  organization: Department of Pediatrics, University of Minnesota Medical School, Minneapolis, Minnesota
– sequence: 4
  givenname: Julie A
  surname: Ritchie
  fullname: Ritchie, Julie A
  organization: Department of Microbiology and Immunology, SUNY Upstate Medical University, Syracuse, New York
– sequence: 5
  givenname: Elizabeth
  surname: Asiago-Reddy
  fullname: Asiago-Reddy, Elizabeth
  organization: Department of Medicine, SUNY Upstate Medical University, Syracuse, New York
– sequence: 6
  givenname: Linda C
  surname: Bartlett
  fullname: Bartlett, Linda C
  organization: Department of Medicine, SUNY Upstate Medical University, Syracuse, New York
– sequence: 7
  givenname: Ethel
  surname: Cesarman
  fullname: Cesarman, Ethel
  organization: Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, New York
– sequence: 8
  givenname: Dongliang
  surname: Wang
  fullname: Wang, Dongliang
  organization: Department of Public Health and Preventative Medicine, SUNY Upstate Medical University, Syracuse, New York
– sequence: 9
  givenname: Rosemary
  surname: Rochford
  fullname: Rochford, Rosemary
  organization: Department of Microbiology and Immunology, SUNY Upstate Medical University, Syracuse, New York
– sequence: 10
  givenname: Jeffrey N
  surname: Martin
  fullname: Martin, Jeffrey N
  organization: Department of Epidemiology and Biostatistics, University of California, San Francisco, California
– sequence: 11
  givenname: Christine A
  surname: King
  fullname: King, Christine A
  email: kingch@upstate.edu
  organization: Department of Microbiology and Immunology, SUNY Upstate Medical University, Syracuse, New York. kingch@upstate.edu
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30084838$$D View this record in MEDLINE/PubMed
BookMark eNpVkMtOwzAQRS1UBG3hE0BZsknx-BVng1RFQKuCkCiwtRzHhaDWLnFaib_HpQ_Bxr7y3LnjOT3Ucd5ZhC4ADwC4vAacyRQzSgZF8ZxC1DKjR6gLnGcpJYJ3ot57TlEvhE-MgQFmJ-iUYiyZpLKL8kcd2qSw83kyNG291m3tXaJdlUymo7dk7GbW_D7VLpnopQ91MtWN8Qt9ho5neh7s-e7uo9e725dilD483Y-L4UNqGECbMppXFWipOePZTEIprNZlPDGpGBhgAleVJMRwXuaEMSFIlklBcCZIycqM9tHNNne5Khe2Mta1jZ6rZVMvdPOtvK7V_4qrP9S7XysBOVCOY8DVLqDxXysbWrWog4kba2f9KigSWURnLvJo5VuraXwIjZ0dxgBWG-xqg1RtkKqIXUHUEXvsu_z7x0PXnjP9AXjDfm4
CitedBy_id crossref_primary_10_1371_journal_ppat_1008156
crossref_primary_10_1136_bcr_2020_235204
crossref_primary_10_1007_s13555_021_00524_w
crossref_primary_10_1155_2020_8852221
crossref_primary_10_1186_s12981_023_00558_4
crossref_primary_10_3390_v15041011
crossref_primary_10_1093_infdis_jiaa340
crossref_primary_10_3390_diagnostics12051242
crossref_primary_10_1128_JVI_01692_19
crossref_primary_10_1177_0300060519895347
crossref_primary_10_1016_j_jmgm_2023_108539
crossref_primary_10_3389_fcimb_2021_603309
crossref_primary_10_1111_ijd_15895
Cites_doi 10.1371/journal.pntd.0001505
10.1046/j.1523-1747.1998.00359.x
10.1128/JVI.78.8.4207-4223.2004
10.1067/mai.2001.111930
10.1111/j.1365-2222.2011.03848.x
10.1186/1756-8722-4-10
10.1016/j.it.2007.03.003
10.1038/leu.2012.81
10.4049/jimmunol.165.1.211
10.1038/sj.leu.2403992
10.1016/j.ccr.2007.01.015
10.1002/jlb.49.2.197
10.1126/science.1120878
10.1128/JVI.01630-10
10.1084/jem.20042407
10.1038/cmi.2014.73
10.1172/JCI79840
10.1073/pnas.91.26.12755
10.1128/JVI.74.15.7146-7150.2000
10.1016/S0090-4295(01)01258-4
10.1182/blood-2003-11-3816
10.1128/JVI.02976-12
10.1182/blood-2011-07-358432
10.1128/JVI.76.16.8408-8419.2002
10.4049/jimmunol.123.4.1445
10.1371/journal.ppat.1000777
10.1146/annurev.pathol.1.110304.100133
10.5858/arpa.2011-0325-RS
10.1006/viro.1996.8303
10.1016/j.virol.2009.05.011
10.1073/pnas.1716804115
10.1128/JVI.01587-07
10.1111/j.1600-065X.2007.00520.x
10.4049/jimmunol.1202096
10.1016/S0091-6749(87)80276-2
10.1097/00129039-200506000-00009
10.1200/JCO.2005.06.079
10.1189/jlb.0405226
10.1056/NEJM198706253162603
10.1007/978-1-4684-4163-5
10.1111/j.1346-8138.1999.tb02052.x
10.1182/blood-2003-02-0641
10.1182/blood-2012-03-415638
10.1016/S0092-8674(02)00628-1
10.1016/j.jaci.2013.02.011
10.1016/S1471-4906(01)02050-6
10.1128/JVI.01769-06
10.1172/JCI200417803
10.1172/JCI27249
10.1016/j.anndiagpath.2016.06.003
10.1038/ni1158
10.1128/JVI.76.16.8383-8399.2002
10.1159/000236928
10.1128/JVI.78.7.3601-3620.2004
ContentType Journal Article
Copyright 2018 American Association for Cancer Research.
Copyright_xml – notice: 2018 American Association for Cancer Research.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
5PM
DOI 10.1158/1078-0432.CCR-18-0873
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE
CrossRef
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1557-3265
EndPage 5097
ExternalDocumentID 10_1158_1078_0432_CCR_18_0873
30084838
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NCI NIH HHS
  grantid: R01 CA119903
– fundername: NCI NIH HHS
  grantid: UM1 CA181255
– fundername: NIAID NIH HHS
  grantid: R03 AI122221
– fundername: NCI NIH HHS
  grantid: R01 CA102667
– fundername: NCI NIH HHS
  grantid: U54 CA190153
– fundername: NIAID NIH HHS
  grantid: P30 AI027763
GroupedDBID ---
18M
29B
2FS
2WC
34G
39C
476
53G
5GY
5RE
5VS
6J9
ABOCM
ACGFO
ACIWK
ACPRK
ACSVP
ADBBV
ADCOW
ADNWM
AENEX
AFHIN
AFOSN
AFRAH
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BR6
BTFSW
CGR
CS3
CUY
CVF
DIK
DU5
E3Z
EBS
ECM
EIF
EJD
F5P
FRP
GX1
H13
IH2
KQ8
L7B
LSO
NPM
OK1
P0W
P2P
QTD
RCR
RHF
RHI
RNS
SJN
TR2
W2D
W8F
WOQ
YKV
AAYXX
CITATION
7X8
5PM
ID FETCH-LOGICAL-c411t-439dd1a8a5457f81b6eaabb6e02d41c1460dd822c55b9244662778620762b4b73
ISSN 1078-0432
IngestDate Tue Sep 17 21:14:38 EDT 2024
Sat Oct 26 05:00:26 EDT 2024
Fri Aug 23 02:11:37 EDT 2024
Sat Nov 02 12:16:31 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 20
Language English
License 2018 American Association for Cancer Research.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c411t-439dd1a8a5457f81b6eaabb6e02d41c1460dd822c55b9244662778620762b4b73
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
current address: Department of Immunology and Microbiology, University of Colorado, Denver, Aurora, CO.
OpenAccessLink https://clincancerres.aacrjournals.org/content/clincanres/24/20/5085.full.pdf
PMID 30084838
PQID 2084913969
PQPubID 23479
PageCount 13
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_6191350
proquest_miscellaneous_2084913969
crossref_primary_10_1158_1078_0432_CCR_18_0873
pubmed_primary_30084838
PublicationCentury 2000
PublicationDate 2018-10-15
PublicationDateYYYYMMDD 2018-10-15
PublicationDate_xml – month: 10
  year: 2018
  text: 2018-10-15
  day: 15
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Clinical cancer research
PublicationTitleAlternate Clin Cancer Res
PublicationYear 2018
References Tachimoto (2022061107215311500_bib37) 2001; 107
Metz (2022061107215311500_bib7) 2007; 217
Roizman (2022061107215311500_bib27) 1982
Nakayama (2022061107215311500_bib44) 2006; 79
Zhang (2022061107215311500_bib50) 1994; 91
Ghannadan (2022061107215311500_bib38) 1998; 111
King (2022061107215311500_bib21) 2013; 87
Graham (2022061107215311500_bib12) 2013; 190
Molderings (2022061107215311500_bib31) 2011; 4
King (2022061107215311500_bib10) 2002; 76
Stoecker (2022061107215311500_bib14) 2012; 136
Kaleeba (2022061107215311500_bib40) 2006; 311
King (2022061107215311500_bib11) 2000; 74
Sheng-Hsuan Chien (2022061107215311500_bib20) 2016
Mutlu (2022061107215311500_bib26) 2007; 11
Saadalla (2022061107215311500_bib15) 2018; 115
Yang (2022061107215311500_bib32) 2016; 24
Schwartz (2022061107215311500_bib25) 1979; 123
Theoharides (2022061107215311500_bib28) 2001; 58
Galli (2022061107215311500_bib5) 2005; 6
Maltby (2022061107215311500_bib13) 2009; 1796
Akin (2022061107215311500_bib52) 2004; 103
Grundhoff (2022061107215311500_bib2) 2004; 113
Becker (2022061107215311500_bib36) 2015; 12
Maaninka (2022061107215311500_bib4) 2013; 132
Brown (2022061107215311500_bib9) 2011; 85
Yao (2022061107215311500_bib41) 2003; 102
Hagiwara (2022061107215311500_bib3) 1999; 26
Parsons (2022061107215311500_bib22) 2006; 116
Ganem (2022061107215311500_bib1) 2006; 1
Krishnan (2022061107215311500_bib34) 2004; 78
Sharma-Walia (2022061107215311500_bib33) 2004; 78
Giannou (2022061107215311500_bib16) 2015; 125
Glimelius (2022061107215311500_bib18) 2005; 19
Akula (2022061107215311500_bib39) 2002; 108
Lin (2022061107215311500_bib42) 2000; 165
Dvorak (2022061107215311500_bib53) 1991; 49
Rappocciolo (2022061107215311500_bib35) 2008; 82
Sharma-Walia (2022061107215311500_bib46) 2010; 6
Rabenhorst (2022061107215311500_bib17) 2012; 120
Galli (2022061107215311500_bib51) 1995; 107
Furuta (2022061107215311500_bib47) 2012; 6
Mizuno (2022061107215311500_bib19) 2012; 26
Schwartz (2022061107215311500_bib29) 1987; 80
Borer-Reinhold (2022061107215311500_bib30) 2011; 41
Punjabi (2022061107215311500_bib23) 2007; 81
Falus (2022061107215311500_bib49) 2001; 22
Kunder (2022061107215311500_bib8) 2011; 118
Koon (2022061107215311500_bib56) 2005; 23
Moses (2022061107215311500_bib43) 2002; 76
Schwartz (2022061107215311500_bib48) 1987; 316
Pantanowitz (2022061107215311500_bib55) 2005; 13
Douglas (2022061107215311500_bib54) 2009; 390
Metz (2022061107215311500_bib6) 2007; 28
Pollock (2022061107215311500_bib24) 1997; 227
Weller (2022061107215311500_bib45) 2005; 201
References_xml – volume: 6
  start-page: e1505
  year: 2012
  ident: 2022061107215311500_bib47
  article-title: Association of mast cell-derived VEGF and proteases in Dengue shock syndrome
  publication-title: PLoS Negl Trop Dis
  doi: 10.1371/journal.pntd.0001505
  contributor:
    fullname: Furuta
– volume: 111
  start-page: 689
  year: 1998
  ident: 2022061107215311500_bib38
  article-title: Phenotypic characterization of human skin mast cells by combined staining with toluidine blue and CD antibodies
  publication-title: J Invest Dermatol
  doi: 10.1046/j.1523-1747.1998.00359.x
  contributor:
    fullname: Ghannadan
– volume: 78
  start-page: 4207
  year: 2004
  ident: 2022061107215311500_bib33
  article-title: Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 envelope glycoprotein gB induces the integrin-dependent focal adhesion kinase-Src-phosphatidylinositol 3-kinase-rho GTPase signal pathways and cytoskeletal rearrangements
  publication-title: J Virol
  doi: 10.1128/JVI.78.8.4207-4223.2004
  contributor:
    fullname: Sharma-Walia
– volume: 107
  start-page: 302
  year: 2001
  ident: 2022061107215311500_bib37
  article-title: Acquisition and alteration of adhesion molecules during cultured human mast cell differentiation
  publication-title: J Allergy Clin Immunol
  doi: 10.1067/mai.2001.111930
  contributor:
    fullname: Tachimoto
– volume: 41
  start-page: 1777
  year: 2011
  ident: 2022061107215311500_bib30
  article-title: An increase in serum tryptase even below 11.4 ng/mL may indicate a mast cell-mediated hypersensitivity reaction: a prospective study in Hymenoptera venom allergic patients
  publication-title: Clin Exp Allergy
  doi: 10.1111/j.1365-2222.2011.03848.x
  contributor:
    fullname: Borer-Reinhold
– volume: 4
  start-page: 10
  year: 2011
  ident: 2022061107215311500_bib31
  article-title: Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options
  publication-title: J Hematol Oncol
  doi: 10.1186/1756-8722-4-10
  contributor:
    fullname: Molderings
– volume: 28
  start-page: 234
  year: 2007
  ident: 2022061107215311500_bib6
  article-title: Mast cells–key effector cells in immune responses
  publication-title: Trends Immunol
  doi: 10.1016/j.it.2007.03.003
  contributor:
    fullname: Metz
– volume: 26
  start-page: 2269
  year: 2012
  ident: 2022061107215311500_bib19
  article-title: Mast cells promote the growth of Hodgkin's lymphoma cell tumor by modifying the tumor microenvironment that can be perturbed by bortezomib
  publication-title: Leukemia
  doi: 10.1038/leu.2012.81
  contributor:
    fullname: Mizuno
– volume: 165
  start-page: 211
  year: 2000
  ident: 2022061107215311500_bib42
  article-title: Human mast cells transmigrate through human umbilical vein endothelial monolayers and selectively produce IL-8 in response to stromal cell-derived factor-1 alpha
  publication-title: J Immunol
  doi: 10.4049/jimmunol.165.1.211
  contributor:
    fullname: Lin
– volume: 19
  start-page: 2360
  year: 2005
  ident: 2022061107215311500_bib18
  article-title: Angiogenesis and mast cells in Hodgkin lymphoma
  publication-title: Leukemia
  doi: 10.1038/sj.leu.2403992
  contributor:
    fullname: Glimelius
– year: 2016
  ident: 2022061107215311500_bib20
  article-title: Diffuse large B cell lymphoma coexistence with systemic mastocytosis
  publication-title: J Cancer Res Pract
  contributor:
    fullname: Sheng-Hsuan Chien
– volume: 11
  start-page: 245
  year: 2007
  ident: 2022061107215311500_bib26
  article-title: In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: a cell and animal model of virally induced Kaposi's sarcoma
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2007.01.015
  contributor:
    fullname: Mutlu
– volume: 49
  start-page: 197
  year: 1991
  ident: 2022061107215311500_bib53
  article-title: Granule changes of human skin mast cells characteristic of piecemeal degranulation and associated with recovery during wound healing in situ
  publication-title: J Leukoc Biol
  doi: 10.1002/jlb.49.2.197
  contributor:
    fullname: Dvorak
– volume: 311
  start-page: 1921
  year: 2006
  ident: 2022061107215311500_bib40
  article-title: Kaposi's sarcoma-associated herpesvirus fusion-entry receptor: cystine transporter xCT
  publication-title: Science
  doi: 10.1126/science.1120878
  contributor:
    fullname: Kaleeba
– volume: 85
  start-page: 1145
  year: 2011
  ident: 2022061107215311500_bib9
  article-title: Dengue virus infection of mast cells triggers endothelial cell activation
  publication-title: J Virol
  doi: 10.1128/JVI.01630-10
  contributor:
    fullname: Brown
– volume: 201
  start-page: 1961
  year: 2005
  ident: 2022061107215311500_bib45
  article-title: Leukotriene B4, an activation product of mast cells, is a chemoattractant for their progenitors
  publication-title: J Exp Med
  doi: 10.1084/jem.20042407
  contributor:
    fullname: Weller
– volume: 12
  start-page: 192
  year: 2015
  ident: 2022061107215311500_bib36
  article-title: Mast cells as rapid innate sensors of cytomegalovirus by TLR3/TRIF signaling-dependent and -independent mechanisms
  publication-title: Cell Mol Immunol
  doi: 10.1038/cmi.2014.73
  contributor:
    fullname: Becker
– volume: 125
  start-page: 2317
  year: 2015
  ident: 2022061107215311500_bib16
  article-title: Mast cells mediate malignant pleural effusion formation
  publication-title: J Clin Invest
  doi: 10.1172/JCI79840
  contributor:
    fullname: Giannou
– volume: 91
  start-page: 12755
  year: 1994
  ident: 2022061107215311500_bib50
  article-title: Hematopoietic development of vav-/- mouse embryonic stem cells
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.91.26.12755
  contributor:
    fullname: Zhang
– volume: 74
  start-page: 7146
  year: 2000
  ident: 2022061107215311500_bib11
  article-title: Release of vasoactive cytokines by antibody-enhanced dengue virus infection of a human mast cell/basophil line
  publication-title: J Virol
  doi: 10.1128/JVI.74.15.7146-7150.2000
  contributor:
    fullname: King
– volume: 58
  start-page: 605
  year: 2001
  ident: 2022061107215311500_bib28
  article-title: Massive extracellular tryptase from activated bladder mast cells in interstitial cystitis
  publication-title: Urology
  doi: 10.1016/S0090-4295(01)01258-4
  contributor:
    fullname: Theoharides
– volume: 103
  start-page: 3222
  year: 2004
  ident: 2022061107215311500_bib52
  article-title: A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib
  publication-title: Blood
  doi: 10.1182/blood-2003-11-3816
  contributor:
    fullname: Akin
– volume: 87
  start-page: 8779
  year: 2013
  ident: 2022061107215311500_bib21
  article-title: Kaposi's sarcoma-associated Herpes virus Kaposin B induces unique monophosphorylation of STAT3 at Serine 727 and MK2-mediated inactivation of the STAT3 transcriptional repressor TRIM28
  publication-title: J Virol
  doi: 10.1128/JVI.02976-12
  contributor:
    fullname: King
– volume: 118
  start-page: 5383
  year: 2011
  ident: 2022061107215311500_bib8
  article-title: Mast cell modulation of the vascular and lymphatic endothelium
  publication-title: Blood
  doi: 10.1182/blood-2011-07-358432
  contributor:
    fullname: Kunder
– volume: 76
  start-page: 8408
  year: 2002
  ident: 2022061107215311500_bib10
  article-title: Dengue virus selectively induces human mast cell chemokine production
  publication-title: J Virol
  doi: 10.1128/JVI.76.16.8408-8419.2002
  contributor:
    fullname: King
– volume: 123
  start-page: 1445
  year: 1979
  ident: 2022061107215311500_bib25
  article-title: Immunologic release of beta-hexosaminidase and beta-glucuronidase from purified rat serosal mast cells
  publication-title: J Immunol
  doi: 10.4049/jimmunol.123.4.1445
  contributor:
    fullname: Schwartz
– volume: 6
  start-page: e1000777
  year: 2010
  ident: 2022061107215311500_bib46
  article-title: Kaposi's sarcoma associated herpes virus (KSHV) induced COX-2: a key factor in latency, inflammation, angiogenesis, cell survival and invasion
  publication-title: PLoS Pathog
  doi: 10.1371/journal.ppat.1000777
  contributor:
    fullname: Sharma-Walia
– volume: 1
  start-page: 273
  year: 2006
  ident: 2022061107215311500_bib1
  article-title: KSHV infection and the pathogenesis of Kaposi's sarcoma
  publication-title: Annu Rev Pathol
  doi: 10.1146/annurev.pathol.1.110304.100133
  contributor:
    fullname: Ganem
– volume: 136
  start-page: 832
  year: 2012
  ident: 2022061107215311500_bib14
  article-title: Systemic mastocytosis with associated clonal hematologic nonmast cell lineage disease: a clinicopathologic review
  publication-title: Arch Pathol Lab Med
  doi: 10.5858/arpa.2011-0325-RS
  contributor:
    fullname: Stoecker
– volume: 227
  start-page: 168
  year: 1997
  ident: 2022061107215311500_bib24
  article-title: Latent murine cytomegalovirus infection in macrophages
  publication-title: Virology
  doi: 10.1006/viro.1996.8303
  contributor:
    fullname: Pollock
– volume: 390
  start-page: 174
  year: 2009
  ident: 2022061107215311500_bib54
  article-title: Characterization of c-Kit expression and activation in KSHV-infected endothelial cells
  publication-title: Virology
  doi: 10.1016/j.virol.2009.05.011
  contributor:
    fullname: Douglas
– volume: 115
  start-page: 1588
  year: 2018
  ident: 2022061107215311500_bib15
  article-title: Mast cells promote small bowel cancer in a tumor stage-specific and cytokine-dependent manner
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1716804115
  contributor:
    fullname: Saadalla
– volume: 82
  start-page: 4793
  year: 2008
  ident: 2022061107215311500_bib35
  article-title: Human herpesvirus 8 infects and replicates in primary cultures of activated B lymphocytes through DC-SIGN
  publication-title: J Virol
  doi: 10.1128/JVI.01587-07
  contributor:
    fullname: Rappocciolo
– volume: 217
  start-page: 304
  year: 2007
  ident: 2022061107215311500_bib7
  article-title: Mast cells in the promotion and limitation of chronic inflammation
  publication-title: Immunol Rev
  doi: 10.1111/j.1600-065X.2007.00520.x
  contributor:
    fullname: Metz
– volume: 1796
  start-page: 19
  year: 2009
  ident: 2022061107215311500_bib13
  article-title: Mast cells in tumor growth: angiogenesis, tissue remodelling and immune-modulation
  publication-title: Biochim Biophys Acta
  contributor:
    fullname: Maltby
– volume: 190
  start-page: 4676
  year: 2013
  ident: 2022061107215311500_bib12
  article-title: Inflammatory response of mast cells during influenza A virus infection is mediated by active infection and RIG-I signaling
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1202096
  contributor:
    fullname: Graham
– volume: 80
  start-page: 850
  year: 1987
  ident: 2022061107215311500_bib29
  article-title: Release of tryptase together with histamine during the immediate cutaneous response to allergen
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/S0091-6749(87)80276-2
  contributor:
    fullname: Schwartz
– volume: 13
  start-page: 162
  year: 2005
  ident: 2022061107215311500_bib55
  article-title: C-Kit (CD117) expression in AIDS-related, classic, and African endemic Kaposi sarcoma
  publication-title: Appl Immunohistochem Mol Morphol
  doi: 10.1097/00129039-200506000-00009
  contributor:
    fullname: Pantanowitz
– volume: 23
  start-page: 982
  year: 2005
  ident: 2022061107215311500_bib56
  article-title: Imatinib-induced regression of AIDS-related Kaposi's sarcoma
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2005.06.079
  contributor:
    fullname: Koon
– volume: 79
  start-page: 95
  year: 2006
  ident: 2022061107215311500_bib44
  article-title: Prostaglandin E2 promotes degranulation-independent release of MCP-1 from mast cells
  publication-title: J Leukoc Biol
  doi: 10.1189/jlb.0405226
  contributor:
    fullname: Nakayama
– volume: 316
  start-page: 1622
  year: 1987
  ident: 2022061107215311500_bib48
  article-title: Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis
  publication-title: N Engl J Med
  doi: 10.1056/NEJM198706253162603
  contributor:
    fullname: Schwartz
– volume-title: The Herpesviruses
  year: 1982
  ident: 2022061107215311500_bib27
  doi: 10.1007/978-1-4684-4163-5
  contributor:
    fullname: Roizman
– volume: 26
  start-page: 577
  year: 1999
  ident: 2022061107215311500_bib3
  article-title: Mast cell "densities" in vascular proliferations: a preliminary study of pyogenic granuloma, portwine stain, cavernous hemangioma, cherry angioma, Kaposi's sarcoma, and malignant hemangioendothelioma
  publication-title: J Dermatol
  doi: 10.1111/j.1346-8138.1999.tb02052.x
  contributor:
    fullname: Hagiwara
– volume: 102
  start-page: 3900
  year: 2003
  ident: 2022061107215311500_bib41
  article-title: Selective expression of stromal-derived factor-1 in the capillary vascular endothelium plays a role in Kaposi sarcoma pathogenesis
  publication-title: Blood
  doi: 10.1182/blood-2003-02-0641
  contributor:
    fullname: Yao
– volume: 120
  start-page: 2042
  year: 2012
  ident: 2022061107215311500_bib17
  article-title: Mast cells play a protumorigenic role in primary cutaneous lymphoma
  publication-title: Blood
  doi: 10.1182/blood-2012-03-415638
  contributor:
    fullname: Rabenhorst
– volume: 108
  start-page: 407
  year: 2002
  ident: 2022061107215311500_bib39
  article-title: Integrin alpha3beta1 (CD 49c/29) is a cellular receptor for Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) entry into the target cells
  publication-title: Cell
  doi: 10.1016/S0092-8674(02)00628-1
  contributor:
    fullname: Akula
– volume: 132
  start-page: 463
  year: 2013
  ident: 2022061107215311500_bib4
  article-title: Human mast cells arise from a common circulating progenitor
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2013.02.011
  contributor:
    fullname: Maaninka
– volume: 22
  start-page: 648
  year: 2001
  ident: 2022061107215311500_bib49
  article-title: Paracrine and autocrine interactions in melanoma: histamine is a relevant player in local regulation
  publication-title: Trends Immunol
  doi: 10.1016/S1471-4906(01)02050-6
  contributor:
    fullname: Falus
– volume: 81
  start-page: 2449
  year: 2007
  ident: 2022061107215311500_bib23
  article-title: Persistent activation of STAT3 by latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells
  publication-title: J Virol
  doi: 10.1128/JVI.01769-06
  contributor:
    fullname: Punjabi
– volume: 113
  start-page: 124
  year: 2004
  ident: 2022061107215311500_bib2
  article-title: Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis
  publication-title: J Clin Invest
  doi: 10.1172/JCI200417803
  contributor:
    fullname: Grundhoff
– volume: 116
  start-page: 1963
  year: 2006
  ident: 2022061107215311500_bib22
  article-title: KSHV targets multiple leukocyte lineages during long-term productive infection in NOD/SCID mice
  publication-title: J Clin Invest
  doi: 10.1172/JCI27249
  contributor:
    fullname: Parsons
– volume: 24
  start-page: 1
  year: 2016
  ident: 2022061107215311500_bib32
  article-title: The role of mast cells in histologically "normal" appendices following emergency appendectomy in pediatric patients
  publication-title: Ann Diagn Pathol
  doi: 10.1016/j.anndiagpath.2016.06.003
  contributor:
    fullname: Yang
– volume: 6
  start-page: 135
  year: 2005
  ident: 2022061107215311500_bib5
  article-title: Mast cells in the development of adaptive immune responses
  publication-title: Nat Immunol
  doi: 10.1038/ni1158
  contributor:
    fullname: Galli
– volume: 76
  start-page: 8383
  year: 2002
  ident: 2022061107215311500_bib43
  article-title: Kaposi's sarcoma-associated herpesvirus-induced upregulation of the c-kit proto-oncogene, as identified by gene expression profiling, is essential for the transformation of endothelial cells
  publication-title: J Virol
  doi: 10.1128/JVI.76.16.8383-8399.2002
  contributor:
    fullname: Moses
– volume: 107
  start-page: 51
  year: 1995
  ident: 2022061107215311500_bib51
  article-title: Regulation of mouse and human mast cell development, survival and function by stem cell factor, the ligand for the c-kit receptor
  publication-title: Int Arch Allergy Immunol
  doi: 10.1159/000236928
  contributor:
    fullname: Galli
– volume: 78
  start-page: 3601
  year: 2004
  ident: 2022061107215311500_bib34
  article-title: Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent decline of lytic gene expression
  publication-title: J Virol
  doi: 10.1128/JVI.78.7.3601-3620.2004
  contributor:
    fullname: Krishnan
SSID ssj0014104
Score 2.400836
Snippet Kaposi sarcoma (KS) is a vascular tumor initiated by infection of endothelial cells (ECs) with KS-associated herpesvirus (KSHV). KS is dependent on sustained...
Abstract Purpose: Kaposi sarcoma (KS) is a vascular tumor initiated by infection of endothelial cells (ECs) with KS–associated herpesvirus (KSHV). KS is...
Purpose: Kaposi sarcoma (KS) is a vascular tumor initiated by infection of endothelial cells (ECs) with KS-associated herpesvirus (KSHV). KS is dependent on...
SourceID pubmedcentral
proquest
crossref
pubmed
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage 5085
SubjectTerms Adult
Aged
Aged, 80 and over
Biomarkers
Cytokines - metabolism
Disease Susceptibility
Female
Herpesviridae Infections - complications
Herpesviridae Infections - virology
Herpesvirus 8, Human
Humans
Immunohistochemistry
Male
Mast Cells - immunology
Mast Cells - metabolism
Methylhistamines - metabolism
Middle Aged
Models, Biological
Sarcoma, Kaposi - etiology
Sarcoma, Kaposi - metabolism
Sarcoma, Kaposi - pathology
Skin - metabolism
Skin - pathology
Tryptases - metabolism
Title Mast Cell Activation and KSHV Infection in Kaposi Sarcoma
URI https://www.ncbi.nlm.nih.gov/pubmed/30084838
https://www.proquest.com/docview/2084913969
https://pubmed.ncbi.nlm.nih.gov/PMC6191350
Volume 24
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Li9swEBbtFpa9lL6b7QMVegtO_ZLtHINpN3SbHvZRcjOSrbCBbbJ4nUt__X4jyXayTaHtRRjbyGbm02hmNA_GPqooUwslI08IoT2sxNQbRyrwqiTVVZloKUtKcJ59T6aX8de5mPfx8ya7pFGj8tfevJL_4Sruga-UJfsPnO0mxQ1cg78YwWGMf8Xjmbxthjl53yZl26bMnAacnk9_YOnbOCsTy3gqKTyLHMD4EbmtkuZtbmRJAKiHrvxP5yaeuLYQw28aWvuw88mYkwrKG157Jxtd19plzNTYxNa9u29yfb1su3-c423d-2XPloCMPR-hNG3t_KrOBxGYgrA2C3OkndwUkFWhbfvQClabHO0AFPpbYhJaodgvv0VmXAlU9jeOwlGen3kBldC2_U62eHrz0zA1Mg0BbIGYe4Wz20cP2aMQUojE38m8i_-h-NbYpXThq5_2fvOIHbaz7Ootvxkj92Nqt5SUiyfssbMu-MRC5Sl7oFfP2OHMxU88Z2NCDCfE8B4xHIjhhBjeIYYvV9wihjvEvGCXXz5f5FPPNc_wyjgIGg-KZlUFMpNQkdMFjBNadwqjH1ZxUGKD9KsK2mEphIINHlMjgBTmrY_dUcUqjV6yg9V6pV8zHo6lr-JECmiLsapKFWc6qqKo0tgsFlIN2KglTXFja6QUxrYUWUFkLYisBchaBLgGWQfsQ0vAAtKMjqgAv_XmtghBbCpUm4wH7JUlaDdly4kBS3dI3b1AldJ3n6yWV6ZiehJgUuEf_3HON-yox_VbdtDUG_0O2maj3hvU3AEjynp2
link.rule.ids 230,315,783,787,888,27936,27937
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Mast+Cell+Activation+and+KSHV+Infection+in+Kaposi+Sarcoma&rft.jtitle=Clinical+cancer+research&rft.au=Ayers%2C+Leona+W&rft.au=Barbachano-Guerrero%2C+Arturo&rft.au=McAllister%2C+Shane+C&rft.au=Ritchie%2C+Julie+A&rft.date=2018-10-15&rft.eissn=1557-3265&rft.volume=24&rft.issue=20&rft.spage=5085&rft_id=info:doi/10.1158%2F1078-0432.CCR-18-0873&rft_id=info%3Apmid%2F30084838&rft.externalDocID=30084838
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1078-0432&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1078-0432&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1078-0432&client=summon